title: [Guidelines for the treatment of nephrotic syndrome].
mesh_terms: D000367:Age Factors; D000418:Albumins / Q000008:administration & dosage; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D018753:Diet, Protein-Restricted; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D005081:Exercise Therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage; D009404:Nephrotic Syndrome / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage; D020551:Pulse Therapy, Drug
chemical_list: D000418:Albumins; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D011239:Prednisolone; D008775:Methylprednisolone